What is the dosage of Neupogen?

Neupogen is available in 4 dosages, including 0.6 mg/ml Prefilled Syringe 0.8 ml, 0.3 mg/ml Injection 1.6 ml, 0.6 mg/ml Prefilled Syringe 0.5 ml and 0.3 mg/ml Injection 1 ml

Neupogen Prescribing & Dosing Schedule

Q: What is Neupogen made of?

Neupogen contains filgrastim which is a Leukocyte Growth Factor

Q: How is Neupogen administered?

Neupogen is administered as a Injectable

Last Update: Oct, 03 2024

Neupogen(filgrastim)

Neupogen 300 MCG in 0.5 ML Prefilled Syringe

NO BOXED WARNING

Dosage & Administration

* Patients with cancer receiving myelosuppressive chemotherapy or induction and/or consolidation chemotherapy for AML
* Recommended starting dose is 5 mcg/kg/day subcutaneous injection, short intravenous infusion (15 to 30 minutes), or continuous intravenous infusion. See Full Prescribing Information for recommended dosage adjustments and timing of administration

* Patients with cancer undergoing bone marrow transplantation
* 10 mcg/kg/day given as an intravenous infusion no longer than 24 hours. See Full Prescribing Information for recommended dosage adjustments and timing of administration

* Patients undergoing autologous peripheral blood progenitor cell collection and therapy
* 10 mcg/kg/day subcutaneous injection
* Administer for at least 4 days before first leukapheresis procedure and continue until last leukapheresis

* Patients with congenital neutropenia
* Recommended starting dose is 6 mcg/kg subcutaneous injection twice daily

* Patients with cyclic or idiopathic neutropenia
* Recommended starting dose is 5 mcg/kg subcutaneous injection daily

* Patients acutely exposed to myelosuppressive doses of radiation
* 10 mcg/kg/day subcutaneous injection

Get Your Patient on Neupogen

Find restrictionsSee step therapiesCompare coverage options

Neupogen Prescribing Information

Contact Medical Science Liaison

Report Adverse Event

Neupogen Prior Authorization Resources

Most recent state uniform prior authorization forms

Verified: Sep 24, 2024Arizona - Uniform Prior Authorization Form

Verified: Sep 24, 2024Colorado - Uniform Prior Authorization Form

Verified: Sep 24, 2024Hawaii - Uniform Prior Authorization Form

Verified: Sep 24, 2024Illinois - Uniform Prior Authorization Form

Verified: Sep 24, 2024Indiana - Uniform Prior Authorization Form

Verified: Sep 24, 2024Louisiana - Uniform Prior Authorization Form

Verified: Sep 24, 2024Minnesota - Uniform Prior Authorization Form

Verified: Sep 24, 2024New Hampshire - Uniform Prior Authorization Form

Verified: Sep 24, 2024New Mexico - Uniform Prior Authorization Form

Verified: Sep 24, 2024Oregon - Uniform Prior Authorization Form

Verified: Sep 24, 2024Texas - Uniform Prior Authorization Form

Verified: Sep 05, 2024Washington - Uniform Prior Authorization Form

Verified: Sep 05, 2024Wisconsin - Uniform Prior Authorization Form

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information

Neupogen Financial Assistance Options

Copay savings program

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form